ELATROL

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

AMITRIPTYLINE HYDROCHLORIDE

Disponible desde:

TEVA ISRAEL LTD

Código ATC:

N06AA09

formulario farmacéutico:

TABLETS

Composición:

AMITRIPTYLINE HYDROCHLORIDE 25 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Área terapéutica:

AMITRIPTYLINE

indicaciones terapéuticas:

Relief of symptoms of depression.Endogenous depression is more likely to be alleviated than are other depressive states.Enuresis nocturna.

Fecha de autorización:

2021-01-31

Información para el usuario

Amitriptyline-10mg-25mg-tabs-PIL-29C-KK-05-2022_
ENG-D11-F
Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
Elatrol
Tablets
Composition
Each tablet contains:
Amitriptyline Hydrochloride 25 mg
Elatrolet
Tablets
Composition
Each tablet contains:
Amitriptyline Hydrochloride 10 mg
For
information
about
inactive
ingredients
and
allergens,
see
section
2
under
‘Important information about some of this medicine’s
ingredients’ and section 6 -
‘Additional information’.
Read the entire leaflet carefully before you start using this
medicine. This leaflet
contains concise information about this medicine. If you have any
further questions,
consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It
may harm them, even if it seems to you that their illness is similar
to yours.
1.
What is this medicine intended for?
Medical activity
For the treatment of symptoms of depression and treatment of
bed-wetting at night
(enuresis nocturna).
Therapeutic group
Non-selective monoamine reuptake inhibitors (N06AA).
2.
Before using this medicine
Do not use this medicine if:

you are sensitive to the active ingredient or to any of the other
ingredients in
this medicine (see section 6 - ‘Additional information’)

you have recently had a heart attack (myocardial infarction)

you have any heart problems such as: disturbances in heart rhythm
which are
seen on an electrocardiogram (ECG), heart block, or coronary artery
disease

you are taking monoamine oxidase inhibitors (MAOIs)

you have taken MAOIs within the last 14 days

you have taken moclobemide the day before
Page 2 of 11
Elatrol-Elatrolet-PIL-notif-KK-05-2022_ENG-D11-F_clean-word

you have severe liver disease

you are treated with Elatrol/Elatrolet tablets, you have to stop
taking this
medicine and wait for 14 days before starting treatment with a MAOI.

you are below 12 years of age.
Sp